PARNAX LAB LTD.
BSE: 506128
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 0.25-90.8% | 2.71+59.2% | 1.70-13.5% | 1.97+135.1% | 0.84-15.1% | 0.99-35.8% | 1.54 |
| Other Income | 1.76+702.1% | 0.22+11.7% | 0.20+5.2% | 0.19-1.3% | 0.19+13.4% | 0.17-7.7% | 0.18 |
| Total Income | 2.01-31.3% | 2.93+54.3% | 1.90-11.9% | 2.15+109.9% | 1.03-11.0% | 1.15-32.8% | 1.72 |
| EXPENSES | |||||||
| Expenditure | 3.28+67.6% | 1.96+58.1% | 1.24-32.8% | 1.84+61.7% | 1.14+20.2% | 0.95-30.1% | 1.35 |
| Tax | -0.73-401.3% | 0.24+44.1% | 0.17+112.8% | 0.08+379.2% | -0.03-159.0% | 0.05-47.3% | 0.09 |
| PROFIT | |||||||
| PBT | -1.28-234.5% | 0.95+43.8% | 0.66+110.7% | 0.31+380.5% | -0.11-154.3% | 0.21-42.9% | 0.36 |
| Net Profit | -0.55-177.5% | 0.71+43.7% | 0.49+110.0% | 0.23+381.0% | -0.08-152.9% | 0.16-41.7% | 0.27 |
| KEY METRICS | |||||||
| OPM % | -100.00%-127.68pp | 27.68%-1.53pp | 29.21%+21.45pp | 7.76%+41.27pp | -33.51%-34.83pp | 1.32%-9.23pp | 10.55% |
| NPM % | -27.35%-51.57pp | 24.22%-1.78pp | 26.00%+15.10pp | 10.90%+19.05pp | -8.15%-21.85pp | 13.70%-2.08pp | 15.78% |
| EPS | 0.48-22.6% | 0.62+44.2% | 0.43+115.0% | 0.20+185.7% | 0.07-50.0% | 0.14-41.7% | 0.24 |
Corporate Events
Board MeetingPARNAXLAB
202628May
Board Meeting
To consider and approve Standalone and Consolidated Audited …
BSE Filing ↗ Board MeetingPARNAXLAB
202613Feb
Board Meeting
Consider and approve Standalone and Consolidated Un-audited …
BSE Filing ↗ Board MeetingPARNAXLAB
202514Nov
Board Meeting
consider and approve Standalone and Consolidated Un-audited …
BSE Filing ↗ Board MeetingPARNAXLAB
202513Aug
Board Meeting
consider and approve Standalone and Consolidated Un-audited …
BSE Filing ↗ Board MeetingPARNAXLAB
202527May
Board Meeting
consider and approve Standalone and Consolidated Audited IND…
BSE Filing ↗ Board MeetingPARNAXLAB
202414Aug
Board Meeting
Consideration And Approval Of Standalone And Consolidated Un…
BSE Filing ↗ Board MeetingPARNAXLAB
202430May
Board Meeting
Consider and approve Standalone and Consolidated Audited Fin…
BSE Filing ↗